Sign in
IDYA Stock Price, Chart, Stats & News
IDEAYA Biosciences, Inc.
Save
IDEAYA Biosciences, Inc. (IDYA) does not currently pay a dividend.
3.49B
Market cap
–
Current P/E
4.65x
Forward P/E
IDYA chart
Fundamentals
Gross margin | 97.90% |
Operating margin | -72.84% |
Pretax margin | -51.99% |
Net margin | -51.99% |
Effective tax rate | – |
ROA | -10.25% |
ROE | -11.10% |
D/E | 0.05x |
Interest coverage ratio | – |
IDYA valuation
P/E | – |
P/S | 12.23x |
P/B | 2.64x |
P/CF | -37.95x |
P/FCF | -36.41x |
P/OCF | -37.95x |
PEG | -0.79x |
EV multiple | -22.69x |
About
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs.
Similar securities
Based on sector and market capitalization
Report issue